124 related articles for article (PubMed ID: 12845725)
1. Bcl-1 rearrangement and cyclin D1 protein expression in multiple myeloma precursor cells.
Liu X; Tang Z; Zou P
J Tongji Med Univ; 2000; 20(2):128-31, 136. PubMed ID: 12845725
[TBL] [Abstract][Full Text] [Related]
2. BCL-1 rearrangement in acute lymphocytic leukemia and its clinical significance.
Liu X; Tang Z
J Tongji Med Univ; 2001; 21(4):283-5. PubMed ID: 12539548
[TBL] [Abstract][Full Text] [Related]
3. Analysis of signal transducer and activator of transcription 3 (Stat 3) pathway in multiple myeloma: Stat 3 activation and cyclin D1 dysregulation are mutually exclusive events.
Quintanilla-Martinez L; Kremer M; Specht K; Calzada-Wack J; Nathrath M; Schaich R; Höfler H; Fend F
Am J Pathol; 2003 May; 162(5):1449-61. PubMed ID: 12707028
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cells.
Katayama Y; Sakai A; Okikawa Y; Oue N; Asaoku H; Sasaki A; Imanaka F; Tsujimoto T; Takimoto Y; Masuda R; Nakaju N; Otsuki T; Yasui W; Kimura A
Int J Oncol; 2004 Sep; 25(3):579-95. PubMed ID: 15289859
[TBL] [Abstract][Full Text] [Related]
5. A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.
Yufu Y; Goto T; Choi I; Uike N; Kozuru M; Ohshima K; Taniguchi T; Motokura T; Yatabe Y; Nakamura S
Cancer; 1999 Apr; 85(8):1750-7. PubMed ID: 10223569
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 overexpression detected by a simple competitive reverse transcription-polymerase chain reaction assay for lymphoid malignancies.
Taniguchi T; Fujita A; Takahashi S; Uchimaru K; Yoshikawa M; Asano S; Fujita T; Motokura T
Jpn J Cancer Res; 1998 Feb; 89(2):159-66. PubMed ID: 9548443
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 overexpression in multiple myeloma. A morphologic, immunohistochemical, and in situ hybridization study of 71 paraffin-embedded bone marrow biopsy specimens.
Athanasiou E; Kaloutsi V; Kotoula V; Hytiroglou P; Kostopoulos I; Zervas C; Kalogiannidis P; Fassas A; Christakis JI; Papadimitriou CS
Am J Clin Pathol; 2001 Oct; 116(4):535-42. PubMed ID: 11601138
[TBL] [Abstract][Full Text] [Related]
8. [Expression of CD68, cyclin D1 and rearrangement of bcl-6 gene are adverse prognostic factors in diffuse large B-cell lymphoma].
Liang X; Wang J; Bai W; Sun R
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):559-64. PubMed ID: 26705179
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
[TBL] [Abstract][Full Text] [Related]
10. Large cell variants of CD5+, CD23- B-cell lymphoma/leukemia.
Dunphy CH; Perkins SL
Arch Pathol Lab Med; 2001 Apr; 125(4):513-8. PubMed ID: 11260626
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression in patients with multiple myeloma.
Troussard X; Avet-Loiseau H; Macro M; Mellerin MP; Malet M; Roussel M; Sola B
Hematol J; 2000; 1(3):181-5. PubMed ID: 11920187
[TBL] [Abstract][Full Text] [Related]
12. Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance.
Hoechtlen-Vollmar W; Menzel G; Bartl R; Lamerz R; Wick M; Seidel D
Br J Haematol; 2000 Apr; 109(1):30-8. PubMed ID: 10848779
[TBL] [Abstract][Full Text] [Related]
13. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
[TBL] [Abstract][Full Text] [Related]
14. Amplification and overexpression of the PRAD1/Cyclin D1 gene in a multiple myeloma cell line.
Sonoki T; Nakazawa N; Hata H; Taniwaki M; Nagasaki A; Seto M; Yoshida M; Kuribayashi N; Kimura T; Harada N; Mitsuya H; Matsuzaki H
Int J Hematol; 1998 Dec; 68(4):459-61. PubMed ID: 9885448
[No Abstract] [Full Text] [Related]
15. Cell cycle analysis and expression of cell cycle regulator genes in myeloma cells overexpressing cyclin D1.
Yata K; Sadahira Y; Otsuki T; Sakaguchi H; Isozaki Y; Uno M; Kurebayashi J; Fujii T; Eda S; Ueki A; Yawata Y; Yamada O; Sugihara T
Br J Haematol; 2001 Sep; 114(3):591-9. PubMed ID: 11552984
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy.
Wilson CS; Butch AW; Lai R; Medeiros LJ; Sawyer JR; Barlogie B; McCourty A; Kelly K; Brynes RK
Br J Haematol; 2001 Mar; 112(3):776-82. PubMed ID: 11260083
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 amplification in multiple myeloma is associated with multidrug resistance expression.
Sewify EM; Afifi OA; Mosad E; Zaki AH; El Gammal SA
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):215-22. PubMed ID: 24468132
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement.
Williams ME; Swerdlow SH
Ann Oncol; 1994; 5 Suppl 1():71-3. PubMed ID: 8172823
[TBL] [Abstract][Full Text] [Related]
19. Frequency and prognostic relevance of cyclin D1 dysregulation in multiple myeloma.
Rasmussen T; Knudsen LM; Johnsen HE
Eur J Haematol; 2001; 67(5-6):296-301. PubMed ID: 11872077
[TBL] [Abstract][Full Text] [Related]
20. Deletion in chromosome 11 and Bcl-1/Cyclin D1 alterations are independently associated with the development of uterine cervical carcinoma.
Singh RK; Dasgupta S; Bhattacharya N; Chunder N; Mondal R; Roy A; Mandal S; Roychowdhury S; Panda CK
J Cancer Res Clin Oncol; 2005 Jun; 131(6):395-406. PubMed ID: 15856299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
